4540 Stock Overview
Manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Tsumura & Co. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥4,339.00 |
| 52 Week High | JP¥5,138.00 |
| 52 Week Low | JP¥2,707.00 |
| Beta | 0.088 |
| 1 Month Change | -7.92% |
| 3 Month Change | -9.45% |
| 1 Year Change | 54.08% |
| 3 Year Change | 30.10% |
| 5 Year Change | 46.64% |
| Change since IPO | 178.14% |
Recent News & Updates
Are Investors Undervaluing Tsumura & Co. (TSE:4540) By 37%?
Feb 03
Tsumura (TSE:4540) Has Announced A Dividend Of ¥68.00
Jan 10These 4 Measures Indicate That Tsumura (TSE:4540) Is Using Debt Reasonably Well
Dec 24Tsumura (TSE:4540) Is Due To Pay A Dividend Of ¥68.00
Dec 06Recent updates
Are Investors Undervaluing Tsumura & Co. (TSE:4540) By 37%?
Feb 03Tsumura (TSE:4540) Has Announced A Dividend Of ¥68.00
Jan 10These 4 Measures Indicate That Tsumura (TSE:4540) Is Using Debt Reasonably Well
Dec 24Tsumura (TSE:4540) Is Due To Pay A Dividend Of ¥68.00
Dec 06Tsumura & Co. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Nov 11Tsumura & Co.'s (TSE:4540) Intrinsic Value Is Potentially 47% Above Its Share Price
Oct 17Tsumura (TSE:4540) Is Increasing Its Dividend To ¥68.00
Sep 26Tsumura & Co.'s (TSE:4540) P/E Still Appears To Be Reasonable
Sep 24Tsumura (TSE:4540) Will Pay A Larger Dividend Than Last Year At ¥68.00
Sep 04Tsumura (TSE:4540) Is Increasing Its Dividend To ¥68.00
Aug 21Tsumura's (TSE:4540) Promising Earnings May Rest On Soft Foundations
Aug 12Tsumura's (TSE:4540) Upcoming Dividend Will Be Larger Than Last Year's
Jul 25Tsumura (TSE:4540) Has Announced That It Will Be Increasing Its Dividend To ¥68.00
Jul 11We Think Tsumura (TSE:4540) Can Stay On Top Of Its Debt
Jun 24News Flash: Analysts Just Made A Sizeable Upgrade To Their Tsumura & Co. (TSE:4540) Forecasts
Mar 28Tsumura (TSE:4540) Will Pay A Dividend Of ¥35.00
Mar 15Earnings Not Telling The Story For Tsumura & Co. (TSE:4540) After Shares Rise 39%
Mar 07Tsumura (TSE:4540) Has Announced A Dividend Of ¥35.00
Feb 26Shareholder Returns
| 4540 | JP Pharmaceuticals | JP Market | |
|---|---|---|---|
| 7D | -5.3% | -2.2% | -1.0% |
| 1Y | 54.1% | 0.7% | 6.1% |
Return vs Industry: 4540 exceeded the JP Pharmaceuticals industry which returned 0.7% over the past year.
Return vs Market: 4540 exceeded the JP Market which returned 6.1% over the past year.
Price Volatility
| 4540 volatility | |
|---|---|
| 4540 Average Weekly Movement | 2.9% |
| Pharmaceuticals Industry Average Movement | 4.0% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in JP Market | 7.5% |
| 10% least volatile stocks in JP Market | 1.8% |
Stable Share Price: 4540 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4540's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1893 | 4,138 | Terukazu Kato | www.tsumura.co.jp |
Tsumura & Co. manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally. The company offers Kampo extract intermediates, granular and prescription Kampo formulations, over-the-counter Kampo medicine, other medications, and herbal bath salts. It offers its products for female problems, proneness to fatigue, skin problems, gastrointestinal problems, obesity, constipation, hemorrhoid, body aches, cold, cough, nasal/throat inflammation, children's sickness, stress, and urinary problems.
Tsumura & Co. Fundamentals Summary
| 4540 fundamental statistics | |
|---|---|
| Market cap | JP¥323.93b |
| Earnings (TTM) | JP¥25.20b |
| Revenue (TTM) | JP¥164.61b |
13.1x
P/E Ratio2.0x
P/S RatioIs 4540 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4540 income statement (TTM) | |
|---|---|
| Revenue | JP¥164.61b |
| Cost of Revenue | JP¥84.35b |
| Gross Profit | JP¥80.26b |
| Other Expenses | JP¥55.06b |
| Earnings | JP¥25.20b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 331.92 |
| Gross Margin | 48.76% |
| Net Profit Margin | 15.31% |
| Debt/Equity Ratio | 22.0% |
How did 4540 perform over the long term?
See historical performance and comparisonDividends
3.1%
Current Dividend Yield36%
Payout RatioDoes 4540 pay a reliable dividends?
See 4540 dividend history and benchmarks| Tsumura dividend dates | |
|---|---|
| Ex Dividend Date | Mar 28 2025 |
| Dividend Pay Date | Jun 30 2025 |
| Days until Ex dividend | 48 days |
| Days until Dividend pay date | 142 days |
Does 4540 pay a reliable dividends?
See 4540 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/07 14:50 |
| End of Day Share Price | 2025/02/07 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Tsumura & Co. is covered by 18 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Company Forecast |
| Kazuaki Hashiguchi | Daiwa Securities Co. Ltd. |
| Anna Kato | Daiwa Securities Co. Ltd. |